- Gebruikers van onderzoeksexpertise:
Manu Vanaerschot obtained his MSc in Biomedical Sciences, with specialisation in Tropical Diseases, at the University of Antwerp, Belgium in 2006. He then started a PhD at the Institute of Tropical Medicine entitled 'Antimonial resistance of Leishmania (Leishmania) donovani: relation with fitness of the parasite and influence on other treatments', which he succesfully defended in 2011.
Since then, Manu Vanaerschot is a postdoctoral researcher at the Institute of Tropical Medicine and is studying the protozoan parasite Leishmania donovani in the context of drug resistance of the parasite and treatment failure of the infected host. He has profiled L. donovani parasites at the genome, transcriptome and metabolome level and tried to link these data to phenotypes related to drug resistance, virulence and general fitness. The impact of these phenotypes on epidemiology and control of the disease has been a central focus of his work, bridging between the lab and the field. In this context he was also the coordinator of the laboratory work packages of the Kaladrug-R project entitled ‘New tools for monitoring drug resistance and treatment response in Visceral Leishmaniasis in the Indian subcontinent’ (www.leishrisk.net/kaladrug).